Uncategorized

At the interbank foreign exchange, the rupee opened at 85.86 and slipped further by 9 paise to 85.96 against the American currency in early trade over its previous close.

GRSE said that it has entered into memorandums of intent and understanding with multiple global partners, marking a strategic move to expand its pipeline beyond defence platforms.

Alvotech and Dr. Reddy’s will collaborate to co-develop a biosimilar candidate to Keytruda (pembrolizumab) for global markets, it said in an exchange filing.

Marc Franklin, Deputy Head of Multi-Asset Solutions for Asia at Manulife Investment Management, noted that the Reserve Bank of India’s room to cut rates could provide support for the cyclical outlook and bank loan growth.

The ratio for the previous auction was 3.07. The 30-year bond pared an earlier gain with the yield falling 2.5 basis points to 2.92% ahead of Thursday’s sale, down from 3.185% last month, the highest level since it was first…

Citi said it expects strength in PB Fintech’s health insurance fresh business, clocking in over 65% growth quarter-to-date, thereby providing higher visibility on future profitability.

Welspun Corp said that since its previous announcement on May 7, 2025, it has received additional orders collectively worth ₹450 crore for its India pipes facility.

On Thursday, market tech analyst Mitessh Thakkar recommended these stocks for the short term.

Out of the 38 analysts that have coverage on Reliance Industries, 36 of them have a ‘Buy’ recommendation on the stock, while two others have a ‘Sell’ rating on the counter.

For financial year 2027, HSBC is projecting Semaglutide sales of $280 million for Dr. Reddy’s, of which $224 million are expected from Canada, assuming a mid-single-digit to low-double-digit unit market share. In a best case scenario, that figure could nearly…